ACA
IMMU
Avoro Capital Advisors’s Immunomedics Inc IMMU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-26,250,000
| Closed | -$2.23B | – | 52 |
|
|
2020
Q3 | $2.23B | Hold |
26,250,000
| – | – | 31.71% | 1 |
|
|
2020
Q2 | $930M | Buy |
26,250,000
+1,750,000
| +7% | +$62M | 18.39% | 1 |
|
|
2020
Q1 | $330M | Hold |
24,500,000
| – | – | 11.15% | 1 |
|
|
2019
Q4 | $518M | Buy |
24,500,000
+3,500,000
| +17% | +$74.1M | 15.22% | 1 |
|
|
2019
Q3 | $278M | Hold |
21,000,000
| – | – | 11.62% | 2 |
|
|
2019
Q2 | $291M | Buy |
21,000,000
+3,285,539
| +19% | +$45.6M | 10.07% | 2 |
|
|
2019
Q1 | $340M | Hold |
17,714,461
| – | – | 14.71% | 1 |
|
|
2018
Q4 | $253M | Hold |
17,714,461
| – | – | 15.11% | 1 |
|
|
2018
Q3 | $369M | Hold |
17,714,461
| – | – | 16.94% | 1 |
|
|
2018
Q2 | $419M | Buy |
17,714,461
+775,000
| +5% | +$18.3M | 16.14% | 1 |
|
|
2018
Q1 | $247M | Buy |
16,939,461
+875,000
| +5% | +$12.8M | 11.82% | 1 |
|
|
2017
Q4 | $260M | Buy |
16,064,461
+1,325,000
| +9% | +$21.4M | 16.83% | 1 |
|
|
2017
Q3 | $206M | Buy |
14,739,461
+4,251,385
| +41% | +$59.4M | 15.98% | 1 |
|
|
2017
Q2 | $92.6M | Hold |
10,488,076
| – | – | 11.69% | 1 |
|
|
2017
Q1 | $67.9M | Buy |
10,488,076
+1,224,736
| +13% | +$7.92M | 8.67% | 1 |
|
|
2016
Q4 | $34M | Buy |
9,263,340
+1,919,163
| +26% | +$7.04M | 6.87% | 2 |
|
|
2016
Q3 | $23.9M | Sell |
7,344,177
-1,212,780
| -14% | -$3.94M | 4.19% | 10 |
|
|
2016
Q2 | $19.9M | Buy |
8,556,957
+7,506,500
| +715% | +$17.4M | 4.41% | 10 |
|
|
2016
Q1 | $2.63M | Buy |
+1,050,457
| New | +$2.63M | 0.92% | 25 |
|